targeting-ace2-for-treatments

Targeting ACE2 for treatments of COVID-19

ACE2 is a membrane protein with an enzymatic domain located on the outer surface of human cells and is the primary target and receptor for the SARS-CoV-2 virus that causes COVID-19.

While many treatments and cures are seeking to address the virus itself, some researchers are intent to find ways to exploit the ACE2 and prevent the spread of Coronavirus ACE2 play a crucial role in host cell invasion by SARS-CoV-2 and efforts are underway to develop drugs that can block its function in this capacity.

Related CAS Insights

Highlights from the CAS Insights webinar on the pharmaceutical patent landscape

White immune cells attacking a large pink cancer cell on a red tissue surface.

New translational research in immuno-oncology may reach patients who do not respond to current therapies

Pharmaceutical capsule containing a glowing orange DNA helix on a dark circuit board background.

CAS Insights Report: Unlocking the future of pharmaceutical innovation through patent intelligence.

Gain new perspectives for faster progress directly to your inbox.